Xenon Pharmaceuticals Financial Health

How is Xenon Pharmaceuticals's financial position?

Financial Health Score

5/6

Financial Health Score 5/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Stable Cash Runway

  • Forecast Cash Runway

Financial Position Analysis

Short Term Liabilities: XENE's short term assets ($794.8M) exceed its short term liabilities ($13.7M).

Long Term Liabilities: XENE's short term assets ($794.8M) exceed its long term liabilities ($7.9M).


Debt to Equity History and Analysis

Debt Level: XENE is debt free.

Reducing Debt: XENE had no debt 5 years ago.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: XENE has sufficient cash runway for more than 3 years based on its current free cash flow.

Forecast Cash Runway: Insufficient data to determine if XENE has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.


Discover healthy companies